Y Intercept Hong Kong Ltd Takes $362,000 Position in Ryan Specialty Holdings Inc. (NYSE:RYAN)

Key Points

• Y Intercept Hong Kong Ltd has acquired a new position in Ryan Specialty Holdings Inc., investing approximately $362,000 for 4,894 shares during the first quarter of the year.
• Ryan Specialty reported a quarterly EPS of $0.39, meeting analysts' expectations, and experienced a 25% increase in revenue year-over-year, totaling $690.17 million.
• The company announced a quarterly dividend of $0.12 per share, with an annualized yield of 0.80% and a dividend payout ratio of 141.18%.

Y Intercept Hong Kong Ltd acquired a new position in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 4,894 shares of the company's stock, valued at approximately $362,000.

Other hedge funds have also made changes to their positions in the company. LPL Financial LLC grew its stake in shares of Ryan Specialty by 19.2% during the fourth quarter. LPL Financial LLC now owns 32,864 shares of the company's stock valued at $2,109,000 after acquiring an additional 5,297 shares in the last quarter. Norges Bank acquired a new stake in shares of Ryan Specialty during the fourth quarter valued at about $78,358,000. Pictet Asset Management Holding SA grew its stake in Ryan Specialty by 21.3% in the fourth quarter. Pictet Asset Management Holding SA now owns 15,302 shares of the company's stock worth $982,000 after purchasing an additional 2,684 shares in the last quarter. Schroder Investment Management Group grew its stake in Ryan Specialty by 2.6% in the fourth quarter. Schroder Investment Management Group now owns 742,571 shares of the company's stock worth $47,317,000 after purchasing an additional 18,623 shares in the last quarter. Finally, RWA Wealth Partners LLC acquired a new position in Ryan Specialty in the fourth quarter worth about $244,000. Institutional investors and hedge funds own 84.82% of the company's stock.

Insider Transactions at Ryan Specialty

In related news, EVP Mark Stephen Katz sold 14,377 shares of the business's stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $65.84, for a total transaction of $946,581.68. Following the completion of the transaction, the executive vice president owned 1,117 shares in the company, valued at $73,543.28. The trade was a 92.79% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director David P. Bolger sold 5,000 shares of Ryan Specialty stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total value of $354,000.00. Following the sale, the director directly owned 71,467 shares in the company, valued at $5,059,863.60. The trade was a 6.54% decrease in their position. The disclosure for this sale can be found here. 52.21% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on RYAN shares. Wells Fargo & Company lowered their price target on shares of Ryan Specialty from $63.00 to $60.00 and set an "equal weight" rating on the stock in a report on Friday. Keefe, Bruyette & Woods lowered their target price on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Morgan Stanley lowered their target price on shares of Ryan Specialty from $80.00 to $78.00 and set an "overweight" rating on the stock in a research note on Monday, July 14th. TD Cowen started coverage on shares of Ryan Specialty in a research note on Thursday, April 10th. They set a "buy" rating and a $89.00 price objective on the stock. Finally, Barclays decreased their price objective on shares of Ryan Specialty from $83.00 to $79.00 and set an "overweight" rating on the stock in a research note on Monday, July 7th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $75.73.

Ryan Specialty Stock Down 5.3%

RYAN traded down $3.22 on Friday, hitting $57.97. The company had a trading volume of 4,994,985 shares, compared to its average volume of 1,055,170. Ryan Specialty Holdings Inc. has a 12-month low of $55.77 and a 12-month high of $77.16. The stock has a market capitalization of $15.21 billion, a price-to-earnings ratio of 170.50, a P/E/G ratio of 1.63 and a beta of 0.66. The company has a debt-to-equity ratio of 3.45, a quick ratio of 1.05 and a current ratio of 1.05. The stock has a fifty day moving average price of $66.68 and a 200-day moving average price of $68.25.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported $0.66 earnings per share for the quarter, hitting analysts' consensus estimates of $0.66. Ryan Specialty had a return on equity of 47.70% and a net margin of 6.97%. The business had revenue of $855.17 million during the quarter, compared to analysts' expectations of $837.52 million. During the same period in the prior year, the business posted $0.58 EPS. The company's revenue was up 23.0% compared to the same quarter last year. Analysts predict that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, August 26th. Shareholders of record on Tuesday, August 12th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, August 12th. Ryan Specialty's dividend payout ratio (DPR) is presently 137.14%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.